In clinical studies, increased HSF1 expression levels are correlated with poor prognosis and advanced metastasis in breast cancer [11,12], non-small cell lung cancer [13], gastric cancer [14], oesophageal squamous cell cancer [15], ovarian cancer [16] and others. Here, HSF1 is linked to ovarian cancer.